Physician profile
Stuart Senkfor
NPI 1215919402
$953.83
in general payments reported to CMS, 2019-2025
8 companies · $98.95 in 2025
The $98.95 reported for 2025 was less than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $95.51 · 2021: $125 · 2022: $13.40 · 2023: $166 · 2024: $285 · 2025: $98.95.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $549.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $549.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $226.47 | 2024-2025 | Tavneos, Krystexxa |
| Horizon Therapeutics Plc | $178.96 | 2022-2023 | Krystexxa |
| Glaxosmithkline, LLC. | $124.99 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $124.74 | 2020-2025 | Jynarque |
| Astrazeneca Pharmaceuticals LP | $109.93 | 2024 | Farxiga |
| Vifor Pharma, INC. | $96.98 | 2019 | |
| Nxstage Medical, INC. | $73.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $18.30 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Senkfor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.